Kyverna Therapeutics Inc.

2.61
-0.23 (-8.10%)
At close: Mar 03, 2025, 3:59 PM
2.59
-0.77%
After-hours: Mar 03, 2025, 04:00 PM EST

Kyverna Therapeutics Balance Sheet Statement

Year FY23 FY22 FY21
Cash & Equivalents 34.65M 37.73M 76.07M
Short-Term Investments 22.9M 13.59M n/a
Long-Term Investments n/a 554K 552K
Other Long-Term Assets 3.92M 678K 41K
Receivables n/a n/a n/a
Inventory n/a n/a n/a
Other Current Assets 3.12M 1.93M 1.02M
Total Current Assets 60.66M 53.25M 77.09M
Property-Plant & Equipment 10.61M 12.44M 7.81M
Goodwill & Intangibles n/a n/a n/a
Total Long-Term Assets 14.53M 13.67M 8.4M
Total Assets 75.19M 66.92M 85.49M
Account Payables 4.36M 1.45M 773K
Deferred Revenue n/a 7.66M 6M
Short-Term Debt 2.92M 2.28M 814K
Other Current Liabilities 12.58M 8.23M 8.34M
Total Current Liabilities 19.86M 11.95M 15.93M
Long-Term Debt 6.16M 8.29M 4.74M
Other Long-Term Liabilities n/a 120.68M 78K
Total Long-Term Liabilities 6.16M 128.97M 115.81M
Total Liabilities 26.02M 140.92M 131.74M
Total Debt 9.08M 10.56M 5.55M
Common Stock n/a n/a n/a
Retained Earnings -136.04M -75.68M -46.78M
Comprehensive Income 4K -26K n/a
Shareholders Equity 49.18M -74M -46.25M
Total Investments 22.9M 13.59M 552K